WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--SeraCare Life Sciences, Inc. (Pink Sheets: SRLS) today announced it has been awarded a seven-year contract valued at $23.7 million to provide management and oversight of disease-study specimens for the National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS). NIAID is a component of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services.
